Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia

被引:121
|
作者
Bora, E. [1 ,2 ,3 ]
Ozerdem, A. [1 ,4 ]
机构
[1] Dokuz Eylul Univ, Dept Psychiat, Fac Med, Izmir, Turkey
[2] Univ Melbourne, Melbourne Neuropsychiat Ctr, Dept Psychiat, Carlton, Vic 3053, Australia
[3] Melbourne Hlth, Carlton, Vic 3053, Australia
[4] Dokuz Eylul Univ, Hlth Sci Inst, Dept Neurosci, Izmir, Turkey
关键词
Bipolar disorder; cognition; longitudinal; mania; schizophrenia; 5-YEAR FOLLOW-UP; I DISORDER; EUTHYMIC PATIENTS; OLDER-ADULTS; METABOLIC SYNDROME; IMPAIRMENT; PERFORMANCE; DEFICITS; LITHIUM; ONSET;
D O I
10.1017/S0033291717001490
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background Bipolar disorder (BP) is associated with significant cognitive impairment. Recent evidence suggests that cognitive deficits are already evident after first-episode mania. However, it is not clear whether BP is associated with further decline in cognitive functions in individuals with established illness. Aim of this meta-analytic review was to examine longitudinal neurocognitive changes in BP and to compare trajectory of cognitive deficits in BP with schizophrenia and healthy controls. Methods Electronic databases were searched for the studies published between January 1987 and November 2016. In total 22 reports were included in the current meta-analysis. The main analysis assessed the longitudinal change in cognition in 643 patients with BP. Further analyses were conducted in studies investigating cognitive changes in BP along with healthy controls (459 BP and 367 healthy controls) and schizophrenia (172 BP and 168 schizophrenia). Results There was no cognitive decline overtime neither in short-term (mean duration = 1.5 years) nor in long-term (mean duration = 5.5 years) follow-up studies in BP. In contrast, there was evidence for modest improvements in task performance in memory and working memory at follow-up. The trajectory of cognitive functioning in BP was not significantly different from changes in schizophrenia and healthy controls. Conclusions Together with the findings in early BP and individuals at genetic risk for BP, current findings suggest that neurodevelopmental factors might play a significant role in cognitive deficits in BP and do not support the notion of progressive cognitive decline in most patients with BP.
引用
收藏
页码:2753 / 2766
页数:14
相关论文
共 50 条
  • [1] Social cognition in schizophrenia in comparison to bipolar disorder: A meta-analysis
    Bora, Emre
    Pantelis, Christos
    SCHIZOPHRENIA RESEARCH, 2016, 175 (1-3) : 72 - 78
  • [2] Neurological soft signs in bipolar disorder in comparison to healthy controls and schizophrenia: A meta-analysis
    Bora, Emre
    Akgul, Ozge
    Ceylan, Deniz
    Ozerdem, Aysegul
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (11) : 1185 - 1193
  • [3] Minor physical anomalies in bipolar disorder in comparison to healthy controls and schizophrenia: A systematic review and meta-analysis
    Bora, Emre
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2022, 65 : 4 - 11
  • [4] Longitudinal studies of cognition in schizophrenia:: meta-analysis
    Szoeke, Andrei
    Trandafir, Anca
    Dupont, Marie-Estelle
    Meary, Alexandre
    Schuerhoff, Franck
    Leboyer, Marion
    BRITISH JOURNAL OF PSYCHIATRY, 2008, 192 (04) : 248 - 257
  • [5] Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls
    Bora, Emre
    Pantelis, Christos
    SCHIZOPHRENIA BULLETIN, 2015, 41 (05) : 1095 - 1104
  • [6] Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls
    Shahab, Saba
    Mulsant, Benoit H.
    Levesque, Melissa L.
    Calarco, Navona
    Nazeri, Arash
    Wheeler, Anne L.
    Foussias, George
    Rajji, Tarek K.
    Voineskos, Aristotle N.
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (05) : 898 - 906
  • [7] Brain structure, cognition, and brain age in schizophrenia, bipolar disorder, and healthy controls
    Saba Shahab
    Benoit H. Mulsant
    Melissa L. Levesque
    Navona Calarco
    Arash Nazeri
    Anne L. Wheeler
    George Foussias
    Tarek K. Rajji
    Aristotle N. Voineskos
    Neuropsychopharmacology, 2019, 44 : 898 - 906
  • [8] A comparison of oxidative metabolism in schizophrenia, schizoaffective disorder, bipolar disorder and healthy controls
    Bulbul, Feridun
    Virit, Osman
    Savas, Haluk
    Altindag, Abdurrahman
    Bulut, Mahmut
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 : S267 - S269
  • [9] META-ANALYSIS OF MAGNETIC RESONANCE IMAGING STUDIES IN BIPOLAR DISORDER AND SCHIZOPHRENIA
    Arnone, D.
    Cavanagh, J.
    Gerber, D.
    Lawrie, S. M.
    Ebmeier, K. P.
    Mcintosh, A. M.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [10] META-ANALYSIS OF MAGNETIC RESONANCE IMAGING STUDIES IN BIPOLAR DISORDER AND SCHIZOPHRENIA
    Arnone, D.
    Cavanagh, J.
    Gerber, D.
    Lawrie, S. M.
    Ebmeier, K. P.
    Mcintosh, A. M.
    EUROPEAN PSYCHIATRY, 2009, 24